Factors Associated With Neurocognitive Impairment Following Chemoradiotherapy in Patients With High-Grade Glioma: Results of a Prospective Trial

BACKGROUND: High-grade gliomas (HGG) are highly fatal tumors despite advanced multimodality management. They are also associated with neurocognitive impairment, both due to disease pathology and treatment. We aimed to assess various risk factors responsible for neurocognitive decline in HGG patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Prashasti, Medhi, Partha Pratim, Kalita, Apurba Kumar, Bhattacharyya, Mouchumee, Nath, Jyotiman, Sarma, Gautam, Yanthan, Yanpothung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409617/
https://www.ncbi.nlm.nih.gov/pubmed/37550818
http://dx.doi.org/10.14791/btrt.2023.0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409617/
https://www.ncbi.nlm.nih.gov/pubmed/37550818
http://dx.doi.org/10.14791/btrt.2023.0004

Ejemplares similares